Paul Peter Tak Candel Therapeutics, Inc. (CADL) insider trading activity
Paul Peter Tak is Chief Executive Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 294,788 shares of CADL, which is worth approximately $2.58 Million. The most recent transaction as insider was on Nov 29, 2024, when has been sold 48,847 shares (Common Stock) at a price of $4.56 per share, resulting in proceeds of $222,742. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
295K
10.87%
3M change
21.09%
12M change
Total Value Held
$2.58 Million
Paul Peter Tak Transaction History
PPT
Paul Peter Tak
Chief Executive Officer
Needham, MA